Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mint Medical Clinic vs Queen RX

Mint Medical Clinic
Graded #433

Lower grade

vs+10.599999999999994
Queen RX
Graded #192

Higher grade

The verdict

Queen RX takes it — 66.3/100 to 55.7/100.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +35
42
77
Dose & formulationMint Medical Clinic +7
64
57
Clinical oversightEven
69
69
Labs & monitoringEven
53
53
FulfillmentQueen RX +23
52
75
Contract termsQueen RX +6
55
61
Mint Medical Clinic · left barQueen RX · right bar

The numbers

MetricMint Medical ClinicQueen RX
WeighScore55.7/10066.3/100
GradeCC
Scorecard rank#433#192
Semaglutide$299/mo (compounded)$100/mo (quarterly plan, compounded)
Tirzepatide$299/mo (compounded)Not disclosed
Coverage1 state45 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Mint Medical Clinic

Graded #433 · C

Strengths

  • Hybrid model with an in-person consultation option for patients who prefer physical care
  • Parent practice disclosed (Balance Medical Clinic)
  • Physical Utah clinic addresses listed on the homepage
  • $299/mo flat starting price, competitive with national DTC providers
  • Broader scope (sexual health, hormones) may suit patients wanting integrated care

Where it loses points

  • Utah only for in-person; telehealth states served not disclosed
  • Pharmacy partner not disclosed
  • LegitScript certification not mentioned
  • 503A vs 503B compounding designation not disclosed
  • No named medical director on the homepage
Queen RX

Graded #192 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard